Q32 Bio Inc. (QTTB) Investment Research Dashboard
About Q32 Bio Inc. (QTTB) stock analysis
Get live QTTB stock price $15.15, comprehensive Q32 Bio Inc. stock analysis, charts, news, sentiment, sector analysis, and expert forecast. Real-time QTTB stock data and investment insights.
Loading chart data...
Q32 Bio Inc. (QTTB) Overview
Q32 Bio Inc. (QTTB) is a publicly traded company in the Healthcare sector , specifically within the Biotechnology industry . As of the latest trading session, QTTB trades at $15.15 with a market capitalization of 193.56M . Over the past 52 weeks, QTTB has traded between $1.57 and $23.57 , with the current price positioned at approximately 62% of this range . The stock currently trades at a pric...
Key Takeaways
- Operates in the Healthcare sector (Biotechnology)
- Market cap: 193.56M
- Current price: $15.15
- 52-week range: $1.57 - $23.57
- P/E ratio: 8.76
Investment Score
A systematic tri-factor framework (valuation, quality, momentum) using trailing twelve-month fundamentals and current price momentum—aligned with the full investment score dashboard.
Score unavailable for this asset.
0-39
Defensive posture
40-54
Mixed / wait for confirmation
55-69
Constructive setup
70-100
Attractive zone
Total Score
Value
Cheapness vs fundamentals and cash generation
Quality
Durability of profitability and balance sheet
Momentum
Price trend strength and persistence
Company Overview
Operating as a clinical-stage biotechnology firm, Q32 Bio Inc. is dedicated to developing biologic therapies aimed at re-establishing healthy immune equilibrium in patients across the United States suffering from autoimmune and inflammatory disorders...
Company Information
- CEO
- Jodie Pope Morrison
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 24
Contact Information
- Website
- https://www.q32bio.com
- Address
- 830 Winter Street
- Country
- US
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
✓ Valuation metrics suggest potential value opportunity (P/E: 8.8)
✓ Lower volatility stock (Beta: -0.27) may provide portfolio stability
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Q32 Bio Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Q32 Bio Inc.
- ⚠Investors should consider how Q32 Bio Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
193.56M
P/E Ratio (TTM)
8.76
Beta
-0.27
Data Sources & Methodology
Financial data on this page is sourced from verified SEC EDGAR filings (10-K, 10-Q, 8-K reports), real-time market data providers, and official company disclosures. All analysis is generated using AI models trained exclusively on reliable financial documents. For detailed information about our data sources and methodology, see our Methodology page.Not investment advice.
Related Stocks
Compare QTTB with peer companies:
- Price
- $4.92+0.00% (1D)
- Market cap
- 177.20M
- Price
- $2.57+1.98% (1D)
- Market cap
- 57.76M
- Price
- $5.34+0.00% (1D)
- Market cap
- 35.98M
- Price
- $4.45+0.45% (1D)
- Market cap
- 12.03M
- Price
- $0.03+0.00% (1D)
- Market cap
- 1.60M
- Price
- $4.24+1.44% (1D)
- Market cap
- 15.32M
- Price
- $3.83+1.32% (1D)
- Market cap
- 9.27M
- Price
- $3.51-1.96% (1D)
- Market cap
- 33.55M
- Price
- $1.26+0.00% (1D)
- Market cap
- 8.43M
- Price
- $5.02-7.72% (1D)
- Market cap
- 53.47M
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.
Healthcare (1D)
84/100 ⭐⭐⭐⭐⭐
- Overall
- +0.2%
- NYSE
- +0.7%
- NASDAQ
- -0.2%
| Sector | 1D | 1W | 1M | P/E | Score |
|---|---|---|---|---|---|
| Financial Services | +0.3% | +0.9% | +3.0% | 19.0 | 85/100⭐⭐⭐⭐⭐ |
| Healthcare | +0.2% | +1.0% | +4.1% | 23.5 | 84/100⭐⭐⭐⭐⭐ |
| Real Estate | +1.8% | +2.1% | -0.3% | 29.7 | 72/100⭐⭐⭐⭐⭐ |
| Communication Services | +0.7% | -2.5% | +2.8% | 21.8 | 62/100⭐⭐⭐⭐ |
| Basic Materials | +0.9% | +0.4% | -1.3% | 24.9 | 55/100⭐⭐⭐⭐ |
| Consumer Defensive | +0.8% | -0.0% | -0.9% | 28.7 | 53/100⭐⭐⭐ |
| Utilities | -0.7% | +2.0% | -1.3% | 25.2 | 52/100⭐⭐⭐ |
| Energy | -0.2% | +0.4% | -2.4% | 19.6 | 49/100⭐⭐⭐ |
| Consumer Cyclical | +0.3% | -3.1% | -2.8% | 43.3 | 14/100⭐ |
| Technology | -1.6% | -0.3% | -3.1% | 42.2 | 14/100⭐ |
| Industrials | -0.5% | -1.3% | -8.9% | 30.4 | 10/100⭐ |
Sector returns combine NYSE and NASDAQ averages. P/E is the latest blended sector multiple. Sector score ranks each sector vs peers using percentile ranks (not fixed thresholds): 48% 1M + 24% 1W + 8% 1D + 20% P/E (lower P/E ranks higher). Data as of 2026-07-27.